BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 31972643)

  • 21. Should Utilization of Lymphadenectomy Vary According to Morphologic Subtype of Intrahepatic Cholangiocarcinoma?
    Zhang XF; Lv Y; Weiss M; Popescu I; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Itaru E; Pawlik TM
    Ann Surg Oncol; 2019 Jul; 26(7):2242-2250. PubMed ID: 30927194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adequate lymph node assessment for extrahepatic bile duct adenocarcinoma.
    Ito K; Ito H; Allen PJ; Gonen M; Klimstra D; D'Angelica MI; Fong Y; DeMatteo RP; Brennan MF; Blumgart LH; Jarnagin WR
    Ann Surg; 2010 Apr; 251(4):675-81. PubMed ID: 20224368
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic Impact of Preoperative Lymph Node Enlargement in Intrahepatic Cholangiocarcinoma: A Multi-Institutional Study by the Kyushu Study Group of Liver Surgery.
    Adachi T; Eguchi S; Beppu T; Ueno S; Shiraishi M; Okuda K; Yamashita Y; Kondo K; Nanashima A; Ohta M; Takami Y; Noritomi T; Kitahara K; Fujioka H
    Ann Surg Oncol; 2015 Jul; 22(7):2269-78. PubMed ID: 25582737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of prognostic factors and implication of lymph node dissection in intrahepatic cholangiocarcinoma: 10-year experience at a tertiary referral center.
    Chang ME; Lei HJ; Chen MH; Yeh YC; Li CP; Hung YP; Hsia CY; Liu CA; Chau GY; Chao Y
    J Chin Med Assoc; 2017 Mar; 80(3):140-146. PubMed ID: 28169208
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival.
    Choi SB; Kim KS; Choi JY; Park SW; Choi JS; Lee WJ; Chung JB
    Ann Surg Oncol; 2009 Nov; 16(11):3048-56. PubMed ID: 19626372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Application value of different lymph node staging system in predicting prognosis of patients with intrahepatic cholangiocarcinoma].
    Chen C; Wu YH; Li Q; Wu H; Qiu YH; Song TQ; Mao XH; He Y; Cheng Z; Zhai WL; Li JD; Geng ZM; Tang ZH
    Zhonghua Wai Ke Za Zhi; 2020 Apr; 58(4):295-302. PubMed ID: 32241060
    [No Abstract]   [Full Text] [Related]  

  • 27. Implications of Intrahepatic Cholangiocarcinoma Etiology on Recurrence and Prognosis after Curative-Intent Resection: a Multi-Institutional Study.
    Zhang XF; Chakedis J; Bagante F; Beal EW; Lv Y; Weiss M; Popescu I; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Groot Koerkamp B; Guglielmi A; Itaru E; Pawlik TM
    World J Surg; 2018 Mar; 42(3):849-857. PubMed ID: 28879598
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of lymph node dissection and a new N-staging system for intrahepatic cholangiocarcinoma: a study from the SEER database.
    Hu H; Zhao H; Cai J
    J Int Med Res; 2021 Jun; 49(6):3000605211012209. PubMed ID: 34098769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathological confirmation of para-aortic lymph node status as a potential criterion for the selection of intrahepatic cholangiocarcinoma patients for radical resection with regional lymph node dissection.
    Nakayama T; Tsuchikawa T; Shichinohe T; Nakamura T; Ebihara Y; Hirano S
    World J Surg; 2014 Jul; 38(7):1763-8. PubMed ID: 24378552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognosis after resection for hepatitis B virus-associated intrahepatic cholangiocarcinoma.
    Wu ZF; Wu XY; Zhu N; Xu Z; Li WS; Zhang HB; Yang N; Yao XQ; Liu FK; Yang GS
    World J Gastroenterol; 2015 Jan; 21(3):935-43. PubMed ID: 25624728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of lymphadenectomy for long-term outcomes in node-negative intrahepatic cholangiocarcinoma: A multicenter study.
    Yoh T; Cauchy F; Le Roy B; Seo S; Taura K; Hobeika C; Dokmak S; Farges O; Gelli M; Sa Cunha A; Adam R; Uemoto S; Soubrane O
    Surgery; 2019 Dec; 166(6):975-982. PubMed ID: 31421869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surgical Indication for Advanced Intrahepatic Cholangiocarcinoma According to the Optimal Preoperative Carbohydrate Antigen 19-9 Cutoff Value.
    Yamamoto Y; Sugiura T; Todaka A; Okamura Y; Ito T; Ashida R; Kakuda Y; Nakanuma Y; Uesaka K
    World J Surg; 2018 Oct; 42(10):3331-3340. PubMed ID: 29619514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surgical Management of Intrahepatic Cholangiocarcinoma: Defining an Optimal Prognostic Lymph Node Stratification Schema.
    Kim Y; Spolverato G; Amini N; Margonis GA; Gupta R; Ejaz A; Pawlik TM
    Ann Surg Oncol; 2015 Aug; 22(8):2772-8. PubMed ID: 25663595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors and Prognostic Significance of Postoperative Complications for Patients with Intrahepatic Cholangiocarcinoma.
    Endo Y; Moazzam Z; Woldesenbet S; Araujo Lima H; Alaimo L; Munir MM; Shaikh CF; Guglielmi A; Aldrighetti L; Weiss M; Bauer TW; Alexandrescu S; Poultsides GA; Kitago M; Maithel SK; Marques HP; Martel G; Pulitano C; Shen F; Cauchy F; Koerkamp BG; Endo I; Pawlik TM
    World J Surg; 2023 Jul; 47(7):1792-1800. PubMed ID: 37010541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recommended Minimal Number of Harvested Lymph Nodes for Intrahepatic Cholangiocarcinoma.
    Kim SH; Han DH; Choi GH; Choi JS; Kim KS
    J Gastrointest Surg; 2021 May; 25(5):1164-1171. PubMed ID: 32378093
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lymph node dissection impact on staging and survival of extrahepatic cholangiocarcinomas, based on U.S. population data.
    Schwarz RE; Smith DD
    J Gastrointest Surg; 2007 Feb; 11(2):158-65. PubMed ID: 17390167
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of microvascular invasion on clinical outcomes after curative-intent resection for intrahepatic cholangiocarcinoma.
    Hu LS; Weiss M; Popescu I; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Itaru E; Pawlik TM
    J Surg Oncol; 2019 Jan; 119(1):21-29. PubMed ID: 30466151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment.
    de Jong MC; Nathan H; Sotiropoulos GC; Paul A; Alexandrescu S; Marques H; Pulitano C; Barroso E; Clary BM; Aldrighetti L; Ferrone CR; Zhu AX; Bauer TW; Walters DM; Gamblin TC; Nguyen KT; Turley R; Popescu I; Hubert C; Meyer S; Schulick RD; Choti MA; Gigot JF; Mentha G; Pawlik TM
    J Clin Oncol; 2011 Aug; 29(23):3140-5. PubMed ID: 21730269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of nodal staging classification and number of examined lymph nodes among patients with ampullary cancer.
    Resende V; Endo Y; Munir MM; Khalil M; Rashid Z; Lima HA; Rawicz-PruszyƄski K; Khan MMM; Katayama E; Tsilimigras DI; Pawlik TM
    J Gastrointest Surg; 2024 Jan; 28(1):33-39. PubMed ID: 38353072
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predicting Lymph Node Metastasis in Intrahepatic Cholangiocarcinoma.
    Tsilimigras DI; Sahara K; Paredes AZ; Moro A; Mehta R; Moris D; Guglielmi A; Aldrighetti L; Weiss M; Bauer TW; Alexandrescu S; Poultsides GA; Maithel SK; Marques HP; Martel G; Pulitano C; Shen F; Soubrane O; Koerkamp BG; Endo I; Pawlik TM
    J Gastrointest Surg; 2021 May; 25(5):1156-1163. PubMed ID: 32757124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.